The estimated Net Worth of Kevin Lobo is at least $87.7 millió dollars as of 21 March 2024. Mr. Lobo owns over 905 units of Stryker stock worth over $43,859,056 and over the last 13 years he sold SYK stock worth over $28,858,859. In addition, he makes $14,974,800 as Chairman of the Board és Chief Executive Officer at Stryker.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Lobo SYK stock SEC Form 4 insiders trading
Kevin has made over 20 trades of the Stryker stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 905 units of SYK stock worth $331,547 on 21 March 2024.
The largest trade he's ever made was exercising 187,470 units of Stryker stock on 2 December 2022 worth over $11,999,955. On average, Kevin trades about 14,657 units every 70 days since 2011. As of 21 March 2024 he still owns at least 119,719 units of Stryker stock.
You can see the complete history of Mr. Lobo stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Kevin Lobo biography
Kevin A. Lobo serves as Chairman of the Board, Chief Executive Officer of the Company. He was named Chairman of the Board in July 2014 and has served as Chief Executive Officer of the Company since 2012. He joined the Company as a Group President in April 2011. Prior thereto, he held leadership roles over eight years with Johnson & Johnson, including president of Ethicon Endo-Surgery. Mr. Lobo is also a director of Parker-Hannifin Corporation, a manufacturer of motion and control technologies and systems. Mr. Lobo's global business and leadership experience across multiple industries, including healthcare, enables him to provide valuable insight to the Board regarding the Company's operations and the strategic planning initiatives necessary to meet the demands of the changing environment. As the sole member of management on our Board, he provides management's business perspectives and the necessary link to the Company's day-to-day operations.
What is the salary of Kevin Lobo?
As the Chairman of the Board és Chief Executive Officer of Stryker, the total compensation of Kevin Lobo at Stryker is $14,974,800. There are no executives at Stryker getting paid more.
How old is Kevin Lobo?
Kevin Lobo is 55, he's been the Chairman of the Board és Chief Executive Officer of Stryker since 2018. There are 9 older and 10 younger executives at Stryker. The oldest executive at Stryker Corp. is Srikant Datar, 67, who is the Independent Director.
What's Kevin Lobo's mailing address?
Kevin's mailing address filed with the SEC is 2825, Airview Boulevard, Kalamazoo, Kalamazoo County, Michigan, 49002, United States.
Insiders trading at Stryker
Over the last 21 years, insiders at Stryker have traded over $2,226,515,535 worth of Stryker stock and bought 219,711 units worth $9,400,673 . The most active insiders traders include Ronda E Stryker, Pat Stryker és Jon L Stryker. On average, Stryker executives and independent directors trade stock every 6 days with the average trade being worth of $10,449,767. The most recent stock trade was executed by Viju Menon on 27 August 2024, trading 600 units of SYK stock currently worth $213,000.
What does Stryker do?
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.
What does Stryker's logo look like?
Complete history of Mr. Lobo stock trades at Parker-Hannifin és Stryker
Stryker executives and stock owners
Stryker executives and other stock owners filed with the SEC include:
-
Kevin Lobo,
Chairman of the Board, Chief Executive Officer -
timothy Scannell,
President, Chief Operating Officer -
Glenn Boehnlein,
Chief Financial Officer, Vice President -
Robert Fletcher,
Vice President, Chief Legal Officer -
Viju Menon,
Group President - Global Quality and Operations -
Kevin A. Lobo,
Chairman, CEO & Pres -
Timothy J. Scannell,
Pres & COO -
Glenn S. Boehnlein,
VP & CFO -
Viju S. Menon,
Group Pres of Global Quality & Operations -
Robert S. Fletcher,
VP & Chief Legal Officer -
Allan Golston,
Lead Independent Director -
Andrew Silvernail,
Independent Director -
Roch Doliveux,
Independent Director -
Sherilyn McCoy,
Independent Director -
Rajeev Suri,
Independent Director -
Ronda Stryker,
Independent Director -
Srikant Datar,
Independent Director -
Mary Brainerd,
Independent Director -
Preston Wells,
Vice President - Investor Relations -
Yin Becker,
Vice President - Communications, Public Affairs and Corporate Marketing -
William Berry,
Principal Accounting Officer, Vice President, Corporate Controller -
M. Kathryn Fink,
Chief Human Resource Officer, Vice President -
M. Kathryn Fink,
VP & Chief HR Officer -
William E. Berry Jr.,
VP & Chief Accounting Officer -
Dana S. McMahon,
VP & Chief Compliance Officer -
Alan Douville,
VP, Chief Information Officer & Chief Information Security Officer -
Robert C. Cohen,
CTO and VP of Global R&D - Joint Replacement -
Louise Francesconi,
Director -
David Floyd,
Group President, Orthopaedics -
Bijoy Sagar,
VP, Chief Information Officer -
Howard E Jr Cox,
Director -
Graham A Mc Lean,
President, Asia-Pacific -
Lonny J Carpenter,
Group President -
Michael Damon Hutchinson,
General Counsel -
Katherine Ann Owen,
VP, Strategy and IR -
William R Jellison,
VP and CFO -
Curtis E Hall,
VP, General Counsel -
Steven P Benscoter,
VP, Human Resources -
Howard L Lance,
Director -
Donald M Engelman,
Director -
Andrew Grant Fox Smith,
President -
Michael P Mogul,
Group President -
Tony M Mc Kinney,
V.P., CAO -
Stephen P Macmillan,
President and COO -
Marcia S Kaminsky,
V.P., Comms. & Public Affairs -
Michael W Rude,
VP of Human Resources -
Curt R Hartman,
V.P., Finance -
Ramesh Subrahmanian,
Group President, International -
Scott P Bruder,
VP, Chief Med&Scientific Off. -
Luciano Cattani,
V.P. -
James E Kemler,
Vice President -
Thomas R Winkel,
Vice Pesident -
John W Brown,
Chairman and CEO -
Jon L Stryker,
10% owner -
Pat Stryker,
10% owner -
Jerome H Grossman,
Director -
John S Lillard,
Director -
Dean H Bergy,
Vice President, CFO & Secretar -
James R Lawson,
Vice President -
Gerard Thomas,
10% owner -
Stephen Si Johnson,
Vice President -
Mason Elizebeth S Upjohn,
10% owner -
Edward B Lipes,
Vice President -
William U Parfet,
Director -
Tatum Lisa M Skeete,
Director -
Rachel Ruggeri,
Director -
Giovanni Caforio,
Director -
James Andrew Pierce,
Group President -
Spencer S Stiles,
Group President